Soluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease

被引：4
作者：
Afangbedji, Nowah [1 ,2 ]
Kumari, Namita [1 ]
Diaz, Sharmin [1 ]
Wen, Fayuan [1 ]
Taylor, James G. [1 ,3 ]
Nekhai, Sergei [1 ,3 ,4 ]
Jerebtsova, Marina [4 ,5 ]
机构：
[1] Howard Univ, Ctr Sickle Cell, Washington, DC USA
[2] Howard Univ, Dept Physiol & Biophys, Washington, DC USA
[3] Howard Univ, Dept Med, Washington, DC USA
[4] Howard Univ, Coll Med, Dept Microbiol, Washington, DC USA
[5] Howard Univ, Coll Med, Dept Microbiol, Room 311,520 St NW, Washington, DC 20059 USA
来源：
BLOOD ADVANCES | 2023年 / 7卷 / 09期
基金：
美国国家卫生研究院;
关键词：
UPAR;
D O I：
10.1182/bloodadvances.2022008374
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1854 / 1857
页数：4
相关论文
共 50 条
[41]   Reduced β3-endonexin levels are associated with enhanced urokinase-type plasminogen activator receptor expression in ApoE-/- mice [J].
Besta, F ;
Müller, I ;
Lorenz, M ;
Massberg, S ;
Bültmann, A ;
Cabeza, N ;
Richter, T ;
Kremmer, E ;
Nothdurfter, C ;
Brand, K ;
Gawaz, M .
THROMBOSIS RESEARCH, 2004, 114 (04) :283-292
[42]   A retrospective study of urokinase-type plasminogen activator receptor (uPAR) as a prognostic factor in cancer of the uterine cervix [J].
Toru Sasaki ;
Hirotaka Nishi ;
Chie Nagata ;
Takeshi Nagai ;
Toshitaka Nagao ;
Fumitoshi Terauchi ;
Keiichi Isaka .
International Journal of Clinical Oncology, 2014, 19 :1059-1064
[43]   CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders:: a review [J].
Béné, MC ;
Castoldi, G ;
Knapp, W ;
Rigolin, GM ;
Escribano, L ;
Lemez, P ;
Ludwig, WD ;
Matutes, E ;
Orfao, A ;
Lanza, F ;
van't Veer, M .
LEUKEMIA, 2004, 18 (03) :394-400
[44]   A retrospective study of urokinase-type plasminogen activator receptor (uPAR) as a prognostic factor in cancer of the uterine cervix [J].
Sasaki, Toru ;
Nishi, Hirotaka ;
Nagata, Chie ;
Nagai, Takeshi ;
Nagao, Toshitaka ;
Terauchi, Fumitoshi ;
Isaka, Keiichi .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (06) :1059-1064
[45]   Circulating Levels of Urokinase-Type Plasminogen Activator Receptor and D-Dimer in Patients With Hematological Malignancies [J].
Rubio-Jurado, Benjamin ;
Tello-Gonzalez, Alejandra ;
Bustamante-Chavez, Lill ;
de la Pena, Aurora ;
Riebeling-Navarro, Carlos ;
Hernan Nava-Zavala, Arnulfo .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (10) :621-626
[46]   CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review [J].
M C Béné ;
G Castoldi ;
W Knapp ;
G M Rigolin ;
L Escribano ;
P Lemez ;
W-D Ludwig ;
E Matutes ;
A Orfao ;
F Lanza ;
M van't Veer .
Leukemia, 2004, 18 :394-400
[47]   The Absence of Urokinase-type Plasminogen Activator Receptor Plays a Role in the Insulin-independent Glucose Metabolism [J].
Tomogane, Kanji ;
Kanno, Yosuke ;
Kawashita, Eri ;
Okada, Kiyotaka ;
Takeuchi, Koji ;
Ueshima, Shigeru ;
Matsuo, Osamu ;
Matsuno, Hiroyuki .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2011, 57 (03) :334-339
[48]   Urokinase-type plasminogen activator receptor (uPAR) augments brain damage in a murine model of ischemic stroke [J].
Nagai, Nobuo ;
Okada, Kiyotaka ;
Kawao, Naoyuki ;
Shida, Chikako ;
Ueshima, Shigeru. ;
Collen, Desire ;
Matsuo, Osamu .
NEUROSCIENCE LETTERS, 2008, 432 (01) :46-49
[49]   Circulating miR-10b, soluble urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response [J].
Setiawan, Lyana ;
Setiabudy, Rahajuningsih ;
Kresno, Siti Boedina ;
Sutandyo, Noorwati ;
Syahruddin, Elisna ;
Jovianti, Frederica ;
Nadliroh, Siti ;
Mubarika, Sofia ;
Setiabudy, Rianto ;
Siregar, Nurjati C. .
CANCER BIOMARKERS, 2024, 39 (02) :137-153
[50]   Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma [J].
Wang, Shenqi ;
Jiang, Li ;
Han, Yipeng ;
Chew, Shan Hwu ;
Ohara, Yuuki ;
Akatsuka, Shinya ;
Weng, Liang ;
Kawaguchi, Koji ;
Fukui, Takayuki ;
Sekido, Yoshitaka ;
Yokoi, Kohei ;
Toyokuni, Shinya .
ONCOTARGET, 2016, 7 (43) :69565-69578
12345